QualityStocks'  Instablog

Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Fibrocell Science, Inc. (FCSC) is “One to Watch” 0 comments
    Nov 3, 2011 2:35 PM | about stocks: FCSC

    Fibrocell Science, Inc. is a biotechnology company focused on the development of personalized autologous cell therapies for aesthetic, medical and scientific applications. The company’s lead product, LAVIV (azficel-T), is the first and only personalized aesthetic cell therapy approved by the FDA for the improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults.

    LAVIV involves an advanced process that extracts a person’s fibroblast cells from a small skin sample and multiplies them in the Fibrocell Science lab. In normal skin, fibroblasts are responsible for producing collagen. LAVIV is the resulting formulation of a person’s own fibroblast cells, which is then injected into wrinkles. Each person’s formulation of LAVIV is unique because it is made from their own cells.

    Last month, Fibrocell Science began the launch of LAVIV (azficel-T) in major metropolitan areas throughout the U.S. The company also launched mylaviv.com, a new resource for interested patient candidates. This website includes product information, frequently asked questions and will soon feature a physician finder, which will be continually updated as new physicians are trained and begin offering LAVIV in their practices.

    David Pernock, Fibrocell Science Chairman and CEO, recently stated that the company will be offering LAVIV exclusively through board-certified dermatologists and plastic surgeons who have been trained by Fibrocell Science. Initially, the company will target select cities across the country and is on track to expand into other markets next year as more physicians are trained and manufacturing capacity increases.

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: FCSC
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.